KKR crosses 10% ownership in Integer Holdings (ITGR), a $4.3B device maker

KKR Group Partnership L.P. disclosed a stake exceeding 10% in Integer Holdings Corp as of October 15, 2026, crossing the threshold that triggers formal insider reporting obligations under securities law. At that level, KKR is no longer a passive observer. It becomes a reporting insider with influence over how the company is governed.

Integer Holdings is a contract manufacturer of medical devices valued at roughly $4.3 billion. The company makes components and finished devices for some of the largest names in the cardiac, neuromodulation, and orthopedics segments, meaning its fortunes are tightly linked to demand across several high-growth corners of medicine.

A 10% position from a firm the size of KKR is rarely an accident of portfolio drift. Private equity players of this profile typically reach that ownership level with a defined thesis, whether that is pushing for operational changes, exploring a take-private, or positioning ahead of a strategic transaction. The filing itself does not state an intent, but the size of the commitment makes the position difficult to read as purely passive.

For existing shareholders, the presence of a major, engaged institutional owner can cut both ways. Activist-leaning investors tend to sharpen management focus and accelerate value creation timelines, but they also introduce uncertainty about the company's long-term independence. The stock and any related governance developments are worth monitoring closely as KKR's plans, if any, become clearer.